---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-046545"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T23:17:50.365583+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Invizyne completes $15M IPO; shares begin trading on Nasdaq under IZTC

## Summary
- Priced 1,875,000 shares at $8.00; gross proceeds $15M, net proceeds ~$14.3M.
- Concurrent private placement issued 93,750 warrants at $0.125, exercisable at $8.00 for 5 years.
- Underwriter has 45-day option to purchase up to 281,250 additional shares for over-allotments.
- Net proceeds to fund production capacity, business development, repayment of related-party loan, and working capital.
- SAFEs from July 2023 converted into 125,001 shares of common stock upon IPO closing.

## SEC filing metadata
- accession: 0001493152-24-046545
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/0001493152-24-046545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-046545
- JSON: https://secwatch.observer/filing/0001493152-24-046545.json
- Plain text: https://secwatch.observer/filing/0001493152-24-046545.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.